homocysteine has been researched along with Osteoporotic Fractures in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
de Groot, LCPGM; Kiefte-de Jong, JC; Lips, P; Oliai Araghi, S; Ploegmakers, KJ; Stricker, BH; Swart, KMA; Uitterlinden, AG; van der Velde, N; van Dijk, SC; van Schoor, NM; Zillikens, MC | 1 |
Kuroda, T; Ohta, H; Shiraki, M; Uenishi, K | 1 |
Chen, C; Eikelboom, JW; Gommans, J; Hankey, GJ; Rodgers, H; Yi, Q | 1 |
Adebusoye, LA; Alonge, TO; Ebesunun, MO; Umahoin, KO | 1 |
Brouwer-Brolsma, EM; Brug, J; de Groot, LC; Dhonukshe-Rutten, RA; Enneman, AW; Ham, AC; Lips, P; Sohl, E; Swart, KM; Uitterlinden, AG; van der Velde, N; van der Zwaluw, NL; van Dijk, SC; van Meurs, JB; van Schoor, NM; van Wijngaarden, JP; Zillikens, MC | 1 |
Brouwer-Brolsma, EM; Brug, J; de Groot, LC; Dhonukshe-Rutten, RA; Enneman, AW; Ham, AC; Lips, P; Sohl, E; Swart, KM; Uitterlinden, AG; van der Velde, N; van der Zwaluw, NL; van Dijk, SC; van Schoor, NM; van Wijngaarden, JP; Zillikens, MC | 1 |
Cheng, Q; Fan, Y; Lin, W; Shen, J; Zhu, Y | 1 |
de Jonge, R; Enneman, AW; Heil, SG; Hofman, A; Rivadeneira, F; Stolk, L; Uitterlinden, AG; van der Velde, N; van Meurs, JB; Zillikens, MC | 1 |
4 trial(s) available for homocysteine and Osteoporotic Fractures
Article | Year |
---|---|
Long-term effects of folic acid and vitamin-B12 supplementation on fracture risk and cardiovascular disease: Extended follow-up of the B-PROOF trial.
Topics: Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Fractures, Bone; Homocysteine; Humans; Male; Odds Ratio; Osteoporotic Fractures; Placebos; Risk Factors; Vitamin B 12 | 2021 |
The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial.
Topics: Aged; Biomarkers; Cerebrovascular Disorders; Double-Blind Method; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Osteoporotic Fractures; Prospective Studies; Stroke; Treatment Outcome; Vitamin B Complex | 2013 |
Effect of daily vitamin B-12 and folic acid supplementation on fracture incidence in elderly individuals with an elevated plasma homocysteine concentration: B-PROOF, a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Motor Activity; Netherlands; Osteoporotic Fractures; Risk Factors; Treatment Outcome; Vitamin B 12 | 2014 |
A Randomized Controlled Trial to Examine the Effect of 2-Year Vitamin B12 and Folic Acid Supplementation on Physical Performance, Strength, and Falling: Additional Findings from the B-PROOF Study.
Topics: Accidental Falls; Aged; Aged, 80 and over; Aging; Dietary Supplements; Female; Folic Acid; Hand Strength; Homocysteine; Humans; Male; Motor Activity; Osteoporotic Fractures; Physical Fitness; Vitamin B 12 | 2016 |
4 other study(ies) available for homocysteine and Osteoporotic Fractures
Article | Year |
---|---|
Multiple vitamin deficiencies additively increase the risk of incident fractures in Japanese postmenopausal women.
Topics: Absorptiometry, Photon; Aged; Avitaminosis; Bone Density; Female; Homocysteine; Humans; Incidence; Japan; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Risk Factors; Vitamin B Deficiency; Vitamin D; Vitamin D Deficiency; Vitamin K Deficiency | 2019 |
Plasma homocysteine, B vitamins and bone mineral density in osteoporosis: a possible risk for bone fracture.
Topics: Body Mass Index; Bone Density; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Nigeria; Osteoporosis; Osteoporotic Fractures; Risk Factors; Vitamin B 12; Vitamin B 6 | 2014 |
Plasma homocysteine level is a risk factor for osteoporotic fractures in elderly patients.
Topics: Aged; Aged, 80 and over; Biomarkers; Bone Density; Female; Homocysteine; Humans; Male; Osteoporotic Fractures; Regression Analysis; Risk Factors | 2016 |
The association between plasma homocysteine levels, methylation capacity and incident osteoporotic fractures.
Topics: Aged; Bone Density; Female; Homocysteine; Humans; Incidence; Linear Models; Methylation; Middle Aged; Netherlands; Osteoporotic Fractures; Proportional Hazards Models; Risk Factors; S-Adenosylhomocysteine; S-Adenosylmethionine | 2012 |